Bain Capital Life Sciences Investors, LLC's most recent trades

10% Owner

%

COMPANY

SHARES

NET TOTAL

19.24%

SPRINGWORKS THERAPEUTICS INC

4,831,307

$118,947,000.00

17.14%

DYNAVAX TECHNOLOGIES CORP

8,415,000

$105,945,000.00

11.37%

3,180,601

$70,291,000.00

10.34%

ARCUTIS BIOTHERAPEUTICS INC

3,000,000

$63,930,000.00

6.96%

CRINETICS PHARMACEUTICALS IN

2,305,558

$42,999,000.00

6.48%

MERSANA THERAPEUTICS INC

8,663,673

$40,026,000.00

3.91%

CARA THERAPEUTICS INC

2,647,473

$24,171,000.00

3.74%

NURIX THERAPEUTICS INC

1,822,883

$23,096,000.00

2.89%

PROTAGONIST THERAPEUTICS INC

2,260,572

$17,881,000.00

2.86%

11,622,598

$17,666,000.00

2.86%

ATEA PHARMACEUTICALS INC

2,485,638

$17,648,000.00

1.98%

3,241,628

$12,221,000.00

1.59%

RESEARCH ALLIANCE CORP II

1,000,000

$9,800,000.00

1.37%

ACADIA PHARMACEUTICALS INC

600,523

$8,461,000.00

1.12%

MARINUS PHARMACEUTICALS INC

1,431,058

$6,926,000.00

1.11%

ARYA SCIENCES ACQU CORP IV

700,000

$6,867,000.00

0.98%

SYROS PHARMACEUTICALS INC

6,264,420

$6,031,000.00

0.80%

8,891,758

$4,961,000.00

0.79%

SOLID BIOSCIENCES INC

7,929,918

$4,882,000.00

0.79%

PANACEA ACQUISITION CORP II

500,000

$4,880,000.00

0.78%

BCLS ACQUISITION CORP

487,500

$4,826,000.00

0.47%

X4 PHARMACEUTICALS INC

3,019,540

$2,914,000.00

0.44%

AEGLEA BIOTHERAPEUTICS INC

5,347,689

$2,701,000.00